Amgen (AMGN) and Watson Pharmaceuticals (WPI) will collaborate to develop and market several...

|About: Amgen Inc. (AMGN)|By:, SA News Editor

Amgen (AMGN) and Watson Pharmaceuticals (WPI) will collaborate to develop and market several oncology antibody biosimilar medicines. Under the terms of the agreement, Amgen will assume primary responsibility for development and manufacturing, while Watson will contribute up to $400M in co-development costs, provide development support and will share product development risks.